See All Slides - tctmd.com

Slides

Presentation TCT 2012

Abluminus (Envision Scientific) Program Update

Presenter: Sameer Dani

October 23, 2012

Presentation TCT 2012

Advanced Imaging for Vulnerable Plaque Detection: The Future Is (Almost) Now!

Presenter: Jagat Narula

October 23, 2012

Presentation TCT 2012

Intervention for Claudication Due to Infrapopliteal Disease: Targets and Techniques

Presenter: Hans Krankenberg

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

ELM Presentation(6)

Presenter: Lynn Peng

October 23, 2012

Presentation TCT 2012

Introduction(13)

Presenter: Ralph Verdino

October 23, 2012

Presentation TCT 2012

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

Presenter: Patrick Calvert

October 23, 2012

Presentation TCT 2012

New Devices in the Old World: A European View of Device Development for Heart Failure

Presenter: Stefan Anker

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Advertisement

Slides

Abluminus (Envision Scientific) Program Update

Advanced Imaging for Vulnerable Plaque Detection: The Future Is (Almost) Now!

Intervention for Claudication Due to Infrapopliteal Disease: Targets and Techniques

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

ELM Presentation(6)

Introduction(13)

Should VH-IVUS Be Used as a Clinical Tool to Detect and Treat Vulnerable Plaque TODAY: From PROSPECT to VIVA

New Devices in the Old World: A European View of Device Development for Heart Failure

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content